News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Gentium S.p.A. Hosts Symposium on Defibrotide at EBMT Annual Meeting


4/2/2012 9:49:07 AM

VILLA GUARDIA (COMO), Italy, April 2, 2012 (GLOBE NEWSWIRE) -- Gentium S.p.A. (Nasdaq:GENT) (the "Company") today announced that the Company's lead product, Defibrotide, was the subject of a symposium, "How can defibrotide tackle two critical early complications of HSCT? Current and future concepts for prevention and treatment of GvHD and VOD," on April 1, 2012 at the 38th Annual Meeting of the European Group for Blood and Marrow Transplantation in Geneva, Switzerland.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES